Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The effect of Dnaaf5 gene dosage on primary ciliary dyskinesia phenotypes
Amjad Horani, … , Susan K. Dutcher, Steven L. Brody
Amjad Horani, … , Susan K. Dutcher, Steven L. Brody
Published April 27, 2023
Citation Information: JCI Insight. 2023;8(11):e168836. https://doi.org/10.1172/jci.insight.168836.
View: Text | PDF
Resource and Technical Advance Genetics Pulmonology

The effect of Dnaaf5 gene dosage on primary ciliary dyskinesia phenotypes

  • Text
  • PDF
Abstract

DNAAF5 is a dynein motor assembly factor associated with the autosomal heterogenic recessive condition of motile cilia, primary ciliary dyskinesia (PCD). The effects of allele heterozygosity on motile cilia function are unknown. We used CRISPR-Cas9 genome editing in mice to recreate a human missense variant identified in patients with mild PCD and a second, frameshift-null deletion in Dnaaf5. Litters with Dnaaf5 heteroallelic variants showed distinct missense and null gene dosage effects. Homozygosity for the null Dnaaf5 alleles was embryonic lethal. Compound heterozygous animals with the missense and null alleles showed severe disease manifesting as hydrocephalus and early lethality. However, animals homozygous for the missense mutation had improved survival, with partially preserved cilia function and motor assembly observed by ultrastructure analysis. Notably, the same variant alleles exhibited divergent cilia function across different multiciliated tissues. Proteomic analysis of isolated airway cilia from mutant mice revealed reduction in some axonemal regulatory and structural proteins not previously reported in DNAAF5 variants. Transcriptional analysis of mouse and human mutant cells showed increased expression of genes coding for axonemal proteins. These findings suggest allele-specific and tissue-specific molecular requirements for cilia motor assembly that may affect disease phenotypes and clinical trajectory in motile ciliopathies.

Authors

Amjad Horani, Deepesh Kumar Gupta, Jian Xu, Huihui Xu, Lis del Carmen Puga-Molina, Celia M. Santi, Sruthi Ramagiri, Steven K. Brennan, Jiehong Pan, Jeffrey R. Koenitzer, Tao Huang, Rachael M. Hyland, Sean P. Gunsten, Shin-Cheng Tzeng, Jennifer M. Strahle, Pleasantine Mill, Moe R. Mahjoub, Susan K. Dutcher, Steven L. Brody

×

Figure 1

The effect of NULL and MIS allele dose on survival.

Options: View larger image (or click on image) Download as PowerPoint
The effect of NULL and MIS allele dose on survival.
(A) Nasal epithelial...
(A) Nasal epithelial cells were obtained from patients with DNAAF5 variants for transmission electron microscopy (TEM) to assess DNAAF5 function by the ultrastructure of the ciliary axoneme. Cross section of cilia show normal, truncated, or absent outer dynein arm (ODA) and inner dynein arm (IDA) (cilia motor complexes) on microtubule doublets. Arrow and arrowhead indicate the ODA and IDA, respectively. Scale bar: 100 nm. (B) Quantification of ODA and IDA identified in TEM cross sections of cilia from individuals with indicated variants in DNAAF5 (n = 1–2 individuals per genotype). (C) Intercross of WT/NULL mice produce no NULL/NULL offspring (n = 31 litters, 173 mice were analyzed). Data are shown as mean ± SEM. Percentage of genotype/litter: 36.9% ± 19.3%, 63.2% ± 19.3%, and 0% in WT/WT, WT/NULL, and NULL/NULL, respectively. (D) Intercross of male WT/MIS and female WT/MIS mice (n = 24 litters). Data are shown as mean ± SEM. Percentage of genotype/litter: 22.9% ± 4.2%, 54.2% ± 5.0%, and 22.9% ± 3.5% in WT/WT, WT/MIS, and MIS/MIS, respectively. (E) Intercross of WT/MIS males with MIS/MIS females (n = 35 litters). Data are shown as mean ± SEM. Percentage of genotype/litter: 57.2% ± 5.0% WT/MIS, 42.8% ± 5.0%, MIS/MIS. Fewer MIS/MIS offspring were produced than predicted by Mendelian genetics (χ2, P = 0.04). (F) Kaplan survival curve for mice with indicated genotypes. (G) Breeding WT/NULL males with MIS/MIS females produce fewer than predicted MIS/NULL offspring (n = 13 litters). Data are shown as mean ± SEM. Percentage of genotype/litter: 81.0% ± 7.0%, WT/MIS; 19.0% ± 7.0%, MIS/NULL; χ2, P = 0.0009. Mean ± SEM are shown in B–E and G; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 determined using Kruskal-Wallis test with Dunn’s multiple comparisons. Number of animals in each group is shown in parenthesis in C–E and G.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts